ARTICLE | Product Development

Will Biocon’s COVID-19 anti-inflammatory succeed where IL-6 blockers have failed?

Biocon is ramping up manufacturing of Alzumab as it prepares to start a large study of the drug

August 1, 2020 12:45 AM UTC
Updated on Aug 12, 2020 at 9:47 PM UTC

Access this Article

BCIQ Company Profiles

Biocon Ltd.